These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Partially Levodopa-Responsive Parkinsonism in a Carrier of a Novel Pathogenic CLTC Variant. Usnich T; Becker LF; Nagel I; Bäumer T; Münchau A Mov Disord Clin Pract; 2024 Jun; 11(6):749-750. PubMed ID: 38586890 [No Abstract] [Full Text] [Related]
7. Severe nigrostriatal degeneration without clinical parkinsonism in patients with polymerase gamma mutations. Tzoulis C; Tran GT; Schwarzlmüller T; Specht K; Haugarvoll K; Balafkan N; Lilleng PK; Miletic H; Biermann M; Bindoff LA Brain; 2013 Aug; 136(Pt 8):2393-404. PubMed ID: 23625061 [TBL] [Abstract][Full Text] [Related]
8. Parkinsonism, cognitive deficit and behavioural disturbance caused by a novel mutation in the polymerase gamma gene. Delgado-Alvarado M; de la Riva P; Jiménez-Urbieta H; Gago B; Gabilondo A; Bornstein B; Rodríguez-Oroz MC J Neurol Sci; 2015 Mar; 350(1-2):93-7. PubMed ID: 25724872 [TBL] [Abstract][Full Text] [Related]
9. Reply to: Partially Levodopa-Responsive Parkinsonism in a Carrier of a Novel Pathogenic CLTC Variant. Nardecchia F; Martinelli S; Pollini L; Leuzzi V Mov Disord Clin Pract; 2024 Jun; 11(6):751-752. PubMed ID: 38616337 [No Abstract] [Full Text] [Related]
10. Mesencephalic complex I deficiency does not correlate with parkinsonism in mitochondrial DNA maintenance disorders. Palin EJ; Paetau A; Suomalainen A Brain; 2013 Aug; 136(Pt 8):2379-92. PubMed ID: 23811324 [TBL] [Abstract][Full Text] [Related]
12. Parkinsonism associated with the homozygous W748S mutation in the POLG1 gene. Remes AM; Hinttala R; Kärppä M; Soini H; Takalo R; Uusimaa J; Majamaa K Parkinsonism Relat Disord; 2008 Dec; 14(8):652-4. PubMed ID: 18321754 [TBL] [Abstract][Full Text] [Related]
13. Novel polymerase gamma (POLG1) gene mutation in the linker domain associated with parkinsonism. Dolhun R; Presant EM; Hedera P BMC Neurol; 2013 Jul; 13():92. PubMed ID: 23865558 [TBL] [Abstract][Full Text] [Related]
14. A novel polymerase gamma mutation in a family with ophthalmoplegia, neuropathy, and Parkinsonism. Mancuso M; Filosto M; Oh SJ; DiMauro S Arch Neurol; 2004 Nov; 61(11):1777-9. PubMed ID: 15534189 [TBL] [Abstract][Full Text] [Related]
15. Late-onset presentation of POLG1-associated mitochondrial disease. Meira B; Roque R; Pinto M; Caetano A BMJ Case Rep; 2019 Mar; 12(3):. PubMed ID: 30936349 [TBL] [Abstract][Full Text] [Related]
16. Sustained dopaminergic response of parkinsonism and depression in POLG-associated parkinsonism. Synofzik M; Asmus F; Reimold M; Schöls L; Berg D Mov Disord; 2010 Jan; 25(2):243-5. PubMed ID: 19998270 [No Abstract] [Full Text] [Related]
17. Alpha-synuclein pathology and Parkinsonism associated with POLG1 mutations and multiple mitochondrial DNA deletions. Betts-Henderson J; Jaros E; Krishnan KJ; Perry RH; Reeve AK; Schaefer AM; Taylor RW; Turnbull DM Neuropathol Appl Neurobiol; 2009 Feb; 35(1):120-4. PubMed ID: 19187065 [No Abstract] [Full Text] [Related]
18. POLG1-related and other "mitochondrial Parkinsonisms": an overview. Orsucci D; Caldarazzo Ienco E; Mancuso M; Siciliano G J Mol Neurosci; 2011 May; 44(1):17-24. PubMed ID: 21221844 [TBL] [Abstract][Full Text] [Related]